Cytokinetics, Incorporated annual gross profit for fiscal 2025 was -$328 million, a decrease of 2.2% from -$321 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Gross Profit | ($328M) | ($321M) | ($323M) | ($146M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $17M | ($87M) | ($97M) | ($46M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CYTK metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All CYTK financial statements → Interactive CYTK charts →
About TickerBase · Data methodology & sources